Identification of an Antimicrobial Agent Effective against Methicillin-Resistant Staphylococcus aureus Persisters

Wooseong Kim1, Annie L Conery2, Rajmohan Rajamuthiah3

  • 1Division of Infectious Diseases, Rhode Island Hospital, Alpert Medical School of Brown University, Providence, Rhode Island, United States of America.

Plos One
|June 4, 2015
PubMed

Insights

Researchers identified a new compound, NH125, that effectively kills antibiotic-tolerant persister cells in Methicillin-resistant Staphylococcus aureus (MRSA) infections. This discovery offers a promising new strategy for treating persistent bacterial infections.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Drug Discovery

Background:

  • Persister cells are a subpopulation of bacteria tolerant to antibiotics, contributing to chronic and difficult-to-treat infections.
  • New therapeutic strategies are needed to effectively eliminate these persister cells.

Purpose of the Study:

  • To develop a high-throughput screening assay for identifying compounds that kill Methicillin-resistant Staphylococcus aureus (MRSA) persisters.
  • To discover novel compounds effective against MRSA persisters and biofilms.

Main Methods:

  • A fluorescence-based screening assay using SYTOX Green dye was developed in a 384-well format.
  • The assay was used to screen a library of compounds, identifying potential persister-killing agents.
  • The efficacy of identified compounds against MRSA persisters and biofilms was evaluated.

Main Results:

  • A robust and high-throughput screening assay (Z`-factor: >0.7) was established.
  • The compound NH125, a histidine kinase inhibitor, was identified as a potent killer of MRSA persisters by inducing membrane permeabilization.
  • NH125 demonstrated bactericidal activity, eradicating persisters at 5 μg/mL within 3 hours and disrupting/eradicating MRSA biofilms at higher concentrations.

Conclusions:

  • The SYTOX Green assay is suitable for large-scale screening to find small molecules effective against MRSA persisters.
  • NH125 shows significant potential as an anti-MRSA drug candidate due to its bactericidal properties and selectivity.
  • The assay is adaptable for identifying compounds against persisters in other bacterial pathogens.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
52
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
2.1K
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
132